beaconbiomedical.com
About Us
http://www.beaconbiomedical.com/about-us.html
Easy, Accurate and Affordable Cancer Screening.Welcome to the Beacon Revolution! It All Starts With an Idea. If early detection saves lives, then why with all the billions of dollars being spent on patient education and awareness as to the life saving benefits of routine cancer screening are we seeing 100's of thousand of people still dying each year from cancer? That question was the genesis behind Beacon Biomedical. Right Test, Right People, Right Place, Right Time. Donald F. Weber, CEO/President.
beaconbiomedical.com
Home
http://www.beaconbiomedical.com/home.html
Beacon Biomedical Inc. Appoints Industry Veteran to Lead Cancer Screening Technology Commercialization. Beacon Biomedical Inc. moves to new corporate offices and announces the opening of its new R&D and CLIA laboratory facilities. Beacon Biomedical Inc. to Present at Singular Research Spring Select "Best of the Uncovereds" Investment Conference on June 9, 2016. Beacon Biomedical Inc. to Exhibit at BIO International Conference in San Francisco on June 6-9, 2016. Congratulations to Beacon Biomedical! Easy,...
beaconbiomedical.com
Portfolio
http://www.beaconbiomedical.com/portfolio.html
Easy, Accurate and Affordable Cancer Screening.Welcome to the Beacon Revolution! In the U.S., the 1/3rd of the women who are noncompli. Ant with recommended early breast cancer screening test and procedures account for 72% of all breast cancer deaths. In the U.S., the 1/3rd of the men and women who are noncompliant with recommended early colorectal cancer screening tests and procedures account for 60% of all colorectal cancer deaths. According to the World Health Organization (WHO), breast cancer is the ...
beaconbiomedical.com
Science
http://www.beaconbiomedical.com/science.html
Easy, Accurate and Affordable Cancer Screening.Welcome to the Beacon Revolution! Licensed Cripto-1 Patents, NIH License Number L-282-2014/0. US Patent No. 7,078,176. PCT Application No. PCT/U. US Provisional Patent Application No. 60/264,643. Canadian Patent No. 2,434,694. Australian Patent No. 2002236871. Europe Patent No. 1370869 (Validated in Germany, France, Italy, Spain, Ireland, Great Britain, Switzerland). Japan Patent No. 3821779. Cripto-1: At the Crossroads of Embryonic Stem Cells and Cancer.
beaconbiomedical.com
Services
http://www.beaconbiomedical.com/services.html
Easy, Accurate and Affordable Cancer Screening.Welcome to the Beacon Revolution! T he Technologies We Choose Are The Ones That You'll Use. At Beacon Biomedical we develop highly accurate, easy to administer and extremely affordable point-of-care tests for the early detection of cancers. This is our business and we do it because we are passionate about saving lives.